Market revenue in 2024 | USD 89.0 million |
Market revenue in 2030 | USD 180.5 million |
Growth rate | 12.6% (CAGR from 2025 to 2030) |
Largest segment | Creams |
Fastest growing segment | Silicon Sheets |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Creams, Gels, Silicon Sheets |
Key market players worldwide | Smith & Nephew PLC, Lumenis, Merz Pharma, Sonoma Pharmaceuticals Inc, Cynosure, CCA Industries Inc, Newmedical, Molnlycke Health Care, Suneva Medical, Pacific World Corporation, Perrigo Co PLC, Enaltus, SCAR |
Creams was the largest segment with a revenue share of 40.34% in 2024. Horizon Databook has segmented the UK topical scar treatment market based on creams, gels, silicon sheets covering the revenue growth of each sub-segment from 2018 to 2030.
The UK topical scar treatment market is growing, largely due to the prevalence of injuries from accidents and burns, which frequently result in scarring. In 2022, 0.21% of the UK population was involved in car accidents, resulting in 143,326 accident-related injuries, according to the Department for Transport’s Annual Report.
Road collisions in Great Britain led to 29,742 casualties classified as killed or seriously injured (KSI). Interestingly, although motorways account for a fifth of all road traffic, they reported fewer casualties, highlighting a higher collision risk on urban and rural roads compared to motorways.
The demand for scar treatments is also fueled by ongoing research and the introduction of innovative products into the market. In March 2023, the UK launched Solution for Scars, the world’s first scientifically proven scar-reduction formula using a natural active ingredient.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account